FOR IMMEDIATE RELEASE

November 10, 2004.

Tecan, a leading player in the health care supply industry, and Dynal Biotech, a world leader in biomagnetic separation, have announced a non-exclusive licensing agreement to co-develop, promote and market optimised robotic applications based on Dynal Biotech research kits (Dynabeads®) for use on Tecan's new Freedom EVO automated platform.

Tecan and Dynal Biotech sign agreement for magnetic bead applications on the Freedom EVO® platform.

Tecan, a leading player in the health care supply industry, and Dynal Biotech, a world leader in biomagnetic separation, have announced a non-exclusive licensing agreement to co-develop, promote and market optimised robotic applications based on Dynal Biotech research kits (Dynabeads®) for use on Tecan's new Freedom EVO automated platform.

The collaboration will combine Dynal Biotech products with Tecan's Freedom EVO automated platforms. In a wide range of settings, the research kits will be used for molecular biology applications involving the separation, isolation and manipulation of biological material (DNA, RNA and proteins). These include cornerstone applications such as nucleic acid extraction and sample preparation, PCR (Polymerase Chain Reaction)- and sequencing reaction clean-up procedures, as well as the isolation of recombinant proteins. Further opportunities for the development of other automated solutions, including those for forthcoming products, will also be considered. Financial details were not disclosed.

Jan Timmers, Executive Vice President Global Marketing at Tecan, commented: "Our collaboration with Dynal Biotech opens up exciting business opportunities for both companies. Going back many years, Dynal Biotech has a proven track record in the development of pioneering magnetic separation technologies for the life sciences. In partnership with Dynal Biotech, we will develop a series of automated solutions allowing key molecular biology applications to be performed on Tecan's Freedom EVO platform." He continued: "By combining magnetic-bead-based application kits with our flexible automated platform, we are convinced that we can significantly impact a wide range of application areas in the genomics market."

Kari E. Krogstad, Vice President Molecular Systems at Dynal Biotech, commented: "Dynal Biotech is very pleased to be working with Tecan on this project. We see strong synergies between our biomagnetic separation technologies and Tecan's flexible platforms for fast and reliable automation." She added: "This partnership is set to deliver considerable benefits to many researchers interested in optimising the performance of key molecular biological applications."

Dynal Biotech has been an innovator in biomagnetic separation technology since 1986. The company provides a wide range of magnetic-bead research kits designed for specific applications in academic and industrial research as well as clinical research and diagnostics. Tecan is a leading provider of powerful modular platforms for liquid handling and robotics. The Freedom EVO series of automated platforms offers state-of-the-art liquid handling capabilities as well as compliance with the very latest regulatory requirements.

About Dynal Biotech

Dynal Biotech (www.dynalbiotech.com) is the world leader in biomagnetic separation techniques for isolation and manipulation of biological material, including cells, nucleic acids, proteins and pathogenic micro-organisms. The company has its head offices in Oslo, Norway, and has R&D and manufacturing facilities in Norway, U.K., China and US Dynal Biotech also has sales subsidiaries in the Germany, France, Australia and Japan.

CONTACTS:

Tecan UK Ltd. Theale Court 11-13 High Street Theale Reading RG7 5AH UK tel. +44-1189-300300 email: tecanuk@tecan.com